Scleroderma

Revision as of 06:40, 13 July 2017 by Mholtz (talk | contribs)

Background

  • Autoimmune disease, aka Systemic Sclerosis
  • Inappropriate and excessive accumulation of collagen and matrix in various tissues
  • Widespread vascular lesions
    • Endothelial dysfunction
    • Vascular spasm
    • Vascular wall thickening
    • Narrowed lumen

Clinical Features

  • Systemic complaints (fever, malaise, fatigue, weight loss, myalgias)
  • Skin lesions (fingers, hands, face)
  • Carpal tunnel
  • Raynaud's phenomenon
  • Interstitial lung disease
  • Renal impairment
  • GI dysmotility
  • GERD/aspiration
  • Chronic esophagitis and stricture formation

Emergencies

Differential Diagnosis

Evaluation

Management

Disposition

See Also

References

  1. Komocsi A, Vorobcsuk A, Faludi R, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2012;51:1027–1036
  2. Nikpour, M., Baron, M. Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies. Curr Opin Rheumatol. 2014;26:131–137
  3. Komocsi A, Vorobcsuk A, Faludi R, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2012;51:1027–1036
  4. Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69:1809–15. doi: 10.1136/ard.2009.114264